跳至主要内容
临床试验/ITMCTR2100005041
ITMCTR2100005041尚未招募1 期

Effect of Tong-Xie-Yao-Fang in the Treatment of CD in remission with Liver Depression and Spleen Deficiency during IFX treatment

First Affiliated Hospital of Zhejiang Chinese Medical University0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1. CD patients have a clinical response in the 10th week after completing IFX induction therapy (?CDAI>=70 points compared with the baseline period of treatment);
  • 2. IFX treatment course >= 1 year;
  • 3. Clinical remission in the 14th week after IFX induction therapy (CDAI<150 points);
  • 4. No severe cardiac insufficiency, no severe pulmonary dysfunction, and basically normal liver and kidney functions.

排除标准

  • 1. Combined nutritional therapy and hormone therapy;
  • 2. Those with other major internal diseases such as respiratory, digestive, blood, cardiovascular, and endocrine diseases.

研究者

发起方
First Affiliated Hospital of Zhejiang Chinese Medical University

相似试验